Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review

@inproceedings{Farrimond2012MemantineAC,
  title={Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review},
  author={Lucy E Farrimond and Emmert Roberts and Rupert H McShane},
  booktitle={BMJ open},
  year={2012}
}
BACKGROUND Memantine is licensed for moderate-to-severe Alzheimer's disease (AD). National Institute for Clinical Excellence (NICE) guidance does not recommend the use of memantine in combination with cholinesterase inhibitors (acetylcholinesterase inhibitor (AChEI)). The underpinning meta-analysis was disputed by the manufacturer. OBJECTIVES To compare… CONTINUE READING